Art. 3 Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…

Content of the Annex to the pharmacovigilance system master file

In forcesince 19 Jun 2012

The pharmacovigilance system master file shall have an Annex containing the following documents:

(1)

a list of medicinal products covered by the pharmacovigilance system master file, including the name of the medicinal product, the international non-proprietary name (INN) of the active substance(s), and the Member State(s) in which the authorisation is valid;

(2)

a list of written policies and procedures for the purpose of complying with Article 11(1);

(3)

the list of subcontracts referred to in Article 6(2);

(4)

a list of the tasks that have been delegated by the qualified person for pharmacovigilance;

(5)

a list of all scheduled and completed audits;

(6)

where applicable, a list of the performance indicators referred to in Article 9;

(7)

where applicable, a list of other pharmacovigilance system master files held by the same marketing authorisation holder;

(8)

a logbook containing the information referred to in Article 5(4).